Naba Al Saha Medical Services Past Earnings Performance
Past criteria checks 1/6
Naba Al Saha Medical Services has been growing earnings at an average annual rate of 2.1%, while the Healthcare industry saw earnings growing at 17.4% annually. Revenues have been growing at an average rate of 17.3% per year. Naba Al Saha Medical Services's return on equity is 10.9%, and it has net margins of 11.7%.
Key information
2.14%
Earnings growth rate
0.43%
EPS growth rate
| Healthcare Industry Growth | 12.28% |
| Revenue growth rate | 17.29% |
| Return on equity | 10.89% |
| Net Margin | 11.70% |
| Last Earnings Update | 30 Jun 2025 |
Recent past performance updates
Recent updates
Naba Al Saha Medical Services Company's (TADAWUL:9546) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Apr 17
Returns On Capital At Naba Al Saha Medical Services (TADAWUL:9546) Paint A Concerning Picture
Mar 18Naba Al Saha Medical Services' (TADAWUL:9546) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Sep 07Returns At Naba Al Saha Medical Services (TADAWUL:9546) Appear To Be Weighed Down
Aug 27We Ran A Stock Scan For Earnings Growth And Naba Al Saha Medical Services (TADAWUL:9546) Passed With Ease
Apr 02The Returns At Naba Al Saha Medical Services (TADAWUL:9546) Aren't Growing
Jan 17Revenue & Expenses Breakdown
How Naba Al Saha Medical Services makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 196 | 23 | 36 | 0 |
| 31 Mar 25 | 195 | 22 | 35 | 0 |
| 31 Dec 24 | 194 | 22 | 35 | 0 |
| 30 Sep 24 | 196 | 30 | 32 | 0 |
| 30 Jun 24 | 197 | 38 | 30 | 0 |
| 31 Mar 24 | 190 | 45 | 29 | 0 |
| 31 Dec 23 | 182 | 52 | 28 | 0 |
| 30 Sep 23 | 165 | 46 | 26 | 0 |
| 30 Jun 23 | 149 | 39 | 23 | 0 |
| 31 Mar 23 | 139 | 33 | 22 | 0 |
| 31 Dec 22 | 130 | 27 | 20 | 0 |
| 30 Sep 22 | 127 | 27 | 20 | 0 |
| 30 Jun 22 | 124 | 27 | 20 | 0 |
| 31 Mar 22 | 121 | 26 | 19 | 0 |
| 31 Dec 21 | 118 | 26 | 18 | 0 |
| 31 Dec 20 | 116 | 27 | 17 | 0 |
Quality Earnings: 9546 has a high level of non-cash earnings.
Growing Profit Margin: 9546's current net profit margins (11.7%) are lower than last year (19.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9546's earnings have grown by 2.1% per year over the past 5 years.
Accelerating Growth: 9546's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 9546 had negative earnings growth (-39.1%) over the past year, making it difficult to compare to the Healthcare industry average (17.2%).
Return on Equity
High ROE: 9546's Return on Equity (10.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/07 15:17 |
| End of Day Share Price | 2025/11/06 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Naba Al Saha Medical Services Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.